AMRX - Amneal Pharmaceuticals, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.05B
Enterprise Value 33.93B
Trailing P/E N/A
Forward P/E 15.77
PEG Ratio (5 yr expected) 10.45
Price/Sales (ttm)1.12
Price/Book (mrq)1.86
Enterprise Value/Revenue 32.14
Enterprise Value/EBITDA 68.87

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -14.68%
Operating Margin (ttm)12.84%

Management Effectiveness

Return on Assets (ttm)5.12%
Return on Equity (ttm)-175.29%

Income Statement

Revenue (ttm)1.83B
Revenue Per Share (ttm)14.40
Quarterly Revenue Growth (yoy)62.10%
Gross Profit (ttm)736.81M
EBITDA 443.33M
Net Income Avi to Common (ttm)-120.34M
Diluted EPS (ttm)-0.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)63.95M
Total Cash Per Share (mrq)0.5
Total Debt (mrq)2.79B
Total Debt/Equity (mrq)349.08
Current Ratio (mrq)2.12
Book Value Per Share (mrq)3.69

Cash Flow Statement

Operating Cash Flow (ttm)114.79M
Levered Free Cash Flow (ttm)195.34M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-62.42%
S&P500 52-Week Change 34.25%
52 Week High 324.48
52 Week Low 36.84
50-Day Moving Average 39.46
200-Day Moving Average 312.70

Share Statistics

Avg Vol (3 month) 3991.08k
Avg Vol (10 day) 3779.48k
Shares Outstanding 5115.56M
Float 91.14M
% Held by Insiders 136.79%
% Held by Institutions 1101.52%
Shares Short (May 31, 2019) 45.75M
Short Ratio (May 31, 2019) 44.16
Short % of Float (May 31, 2019) 416.03%
Short % of Shares Outstanding (May 31, 2019) 41.92%
Shares Short (prior month Apr 30, 2019) 46.98M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A